<SEC-DOCUMENT>0001785530-23-000007.txt : 20230323
<SEC-HEADER>0001785530-23-000007.hdr.sgml : 20230323
<ACCEPTANCE-DATETIME>20230323070129
ACCESSION NUMBER:		0001785530-23-000007
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230323
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230323
DATE AS OF CHANGE:		20230323

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Werewolf Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001785530
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				823523180
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40366
		FILM NUMBER:		23754425

	BUSINESS ADDRESS:	
		STREET 1:		200 TALCOTT AVENUE
		STREET 2:		2ND FLOOR
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		617-952-0555

	MAIL ADDRESS:	
		STREET 1:		200 TALCOTT AVENUE
		STREET 2:		2ND FLOOR
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>howl-20230323.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:51b9a020-69a6-48c0-b62c-27af5e149fe6,g:3439c4dd-2c50-4bed-abb0-2d095016a5f8,d:4fc1022a6d4849038cc9a096deee5b68--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>howl-20230323</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i968f371d1f5347e5b21638551e357926_D20230323-20230323" name="dei:EntityCentralIndexKey" id="f-23">0001785530</ix:nonNumeric><ix:nonNumeric contextRef="i968f371d1f5347e5b21638551e357926_D20230323-20230323" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-24">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="howl-20230323.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i968f371d1f5347e5b21638551e357926_D20230323-20230323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-23</xbrli:startDate><xbrli:endDate>2023-03-23</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4fc1022a6d4849038cc9a096deee5b68_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span><